These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10534282)

  • 21. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 22. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.
    Mohr DC; Likosky W; Dwyer P; Van Der Wende J; Boudewyn AC; Goodkin DE
    Arch Neurol; 1999 Oct; 56(10):1263-5. PubMed ID: 10520943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subacute cutaneous lupus erythematosus and interferon beta-1 a].
    Schmutz J; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Feb; 127(2):237. PubMed ID: 10739993
    [No Abstract]   [Full Text] [Related]  

  • 24. Life-threatening acute pancreatitis associated with interferon beta-1a treatment in multiple sclerosis.
    Midgard R; Ertresvåg K; Trondsen E; Spigset O
    Neurology; 2005 Jul; 65(1):170-1. PubMed ID: 16009917
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cutaneous vasculitis with renal impairment complicating interferon-beta 1a therapy for multiple sclerosis].
    Débat Zoguéreh D; Boucraut J; Beau-Salinas F; Bodiguel E; Lechapois D; Pomet E
    Rev Neurol (Paris); 2004 Nov; 160(11):1081-4. PubMed ID: 15602352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic peripheral retinal hemorrhages as a manifestation of interferon beta 1a retinopathy.
    Bakri SJ; Swanson JW
    Semin Ophthalmol; 2015 Jan; 30(1):56-7. PubMed ID: 23952180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.
    Strueby L; Nair B; Kirk A; Taylor-Gjevre RM
    Scand J Rheumatol; 2005; 34(6):485-8. PubMed ID: 16393774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of interferon β-1a into human breastmilk.
    Hale TW; Siddiqui AA; Baker TE
    Breastfeed Med; 2012 Apr; 7(2):123-5. PubMed ID: 21988602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].
    Spirin NN; Kasatkin DS; Stepanov IO; Shipova EG; Baranova NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):27-33. PubMed ID: 23096035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression in multiple sclerosis associated with interferon beta-1a (Rebif).
    Pandya R; Patten S
    Can J Psychiatry; 2002 Sep; 47(7):686. PubMed ID: 12355685
    [No Abstract]   [Full Text] [Related]  

  • 31. An open labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
    Ozuma J
    J Neurosci Nurs; 1996 Apr; 28(2):72. PubMed ID: 8718753
    [No Abstract]   [Full Text] [Related]  

  • 32. Arthritis during interferon beta-1b treatment in multiple sclerosis.
    Altintas A; Alici Y; Melikoğlu M; Siva A
    Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
    Dionisiotis J; Zoukos Y; Thomaides T
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1079. PubMed ID: 15201386
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial.
    Comi G; De Stefano N; Freedman MS; Barkhof F; Polman CH; Uitdehaag BM; Casset-Semanaz F; Hennessy B; Moraga MS; Rocak S; Stubinski B; Kappos L
    Lancet Neurol; 2012 Jan; 11(1):33-41. PubMed ID: 22146409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis.
    Rosa DJ; Matias Fde A; Cedrim SD; Machado RF; Sá AA; Silva VC
    An Bras Dermatol; 2011; 86(2):336-8. PubMed ID: 21603818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcified subcutaneous nodules: a long-term complication of interferon beta-1a therapy.
    Macbeth AE; Kendall BR; Smith A; Saldanha G; Harman KE
    Br J Dermatol; 2007 Sep; 157(3):624-5. PubMed ID: 17596164
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe urticaria due to recombinant interferon beta-1a.
    Mazzeo L; Ricciardi L; Fazio MC; Fogliani O; Fedele R; Ferlazzo E; Isola S
    Br J Dermatol; 2003 Jan; 148(1):172. PubMed ID: 12534618
    [No Abstract]   [Full Text] [Related]  

  • 39. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b.
    Casoni F; Merelli E; Bedin R; Martella A; Cesinaro A; Bertolotto A
    Mult Scler; 2003 Aug; 9(4):420-3. PubMed ID: 12926849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
    O'Sullivan SS; Cronin EM; Sweeney BJ; Bourke JF; Fitzgibbon J
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1382-3. PubMed ID: 16782776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.